8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Jul 26, 2006)

Filed July 26, 2006For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K on July 26, 2006, to report its second quarter 2006 financial results. The primary purpose of this filing is to disseminate the information contained within a press release issued on the same date, which details the company's financial performance for the quarter ended June 30, 2006. Investors should note that this filing primarily serves as a notification mechanism for the release of financial data. While the press release itself contains the detailed financial results, this 8-K filing's content, including the press release, is not considered 'filed' for certain liability purposes under the Securities Exchange Act of 1934. Therefore, investors should refer directly to the press release, incorporated by reference, for the substantive financial details.

Key Highlights

  • 1Vertex Pharmaceuticals filed an 8-K to report its Q2 2006 financial results.
  • 2The filing date was July 26, 2006.
  • 3The report's core content is a press release dated July 26, 2006, titled 'Vertex Pharmaceuticals Reports Second Quarter 2006 Financial Results'.
  • 4This 8-K serves to formally announce and provide access to the Q2 2006 financial results.
  • 5Information in this 8-K and the attached press release is not considered 'filed' for specific liability purposes under Section 18 of the Exchange Act.
  • 6The press release is incorporated by reference into the 8-K filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to report Vertex Pharmaceuticals' financial results for the second quarter ended June 30, 2006, by incorporating a press release issued on July 26, 2006.

The actual Q2 2006 financial results are contained within the press release titled 'Vertex Pharmaceuticals Reports Second Quarter 2006 Financial Results,' dated July 26, 2006, which is attached as Exhibit 99.1 to this 8-K filing and incorporated by reference.

No, in accordance with General Instruction B-2 of Form 8-K, the information set forth in this Item 2.02 and in Exhibit 99.1 shall not be deemed to be 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other SEC filings, unless expressly stated otherwise.

This 8-K filing itself does not provide the specific financial numbers. It only references that the press release, Exhibit 99.1, contains the company's consolidated financial results for the quarter ended June 30, 2006.